Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

1 tiny electron could be key to furture drugs that repair sunburn

26.07.2011
Researchers who have been working for nearly a decade to piece together the process by which an enzyme repairs sun-damaged DNA have finally witnessed the entire process in full detail in the laboratory.

What they saw contradicts fundamental notions of how key biological molecules break up during the repair of sunburn – and that knowledge could someday lead to drugs or even lotions that could heal sunburn in humans.

In the Proceedings of the National Academy of Sciences, the Ohio State University researchers and their colleagues confirm what was previously known about the enzyme photolyase, which is naturally produced in the cells of plants and some animals – though not in mammals, including humans. The enzyme repairs DNA by tearing open the misshapen, damaged area of the DNA in two places and reforming it into its original, undamaged shape.

But the enzyme doesn't break up the injury in both places at once, as researchers previously suspected from theoretical calculations. Instead, it's a two-step process that sends an electron through the DNA molecule in a circuitous route from one breakup site to the other, the new study revealed.

The research was led by Dongping Zhong, the Robert Smith Professor of Physics and professor in the departments of chemistry and biochemistry at Ohio State.

Zhong and his team literally shed light on the process in the laboratory using a laser with a kind of strobe effect to take super-fast measurements of the enzyme in action.

What they saw surprised them.

The two key chemical bond sites broke up one after the other – the first in just a few trillionths of a second, and the next after a 90-trillionths-of-a-second delay.

The reason? The single electron ejected from the enzyme – the source of energy for the breakup – took time and energy to travel from one bond site to the other, tunneling along the outer edge of the ring-shaped damage site.

Also, it turns out that for the enzyme taking the long way around is the most efficient way for the electron to do the job, Zhong explained.

"The enzyme needs to inject an electron into damaged DNA -- but how?" he said. "There are two pathways. One is direct jump from the enzyme across the ring from one side to the other, which is a short distance. But instead the electron takes the scenic route. We found that along the way, there is another molecule that acts as a bridge to speed the electron flow, and in this way, the long route actually takes less time."

Now that they have revealed how the enzyme actually works, the researchers hope that others can use this knowledge to create synthetic photolyase for drugs or even lotions that can repair DNA.

Ultraviolet (UV) light damages DNA by exciting the atoms in the DNA molecule, causing accidental bonds to form between the atoms. The bond is called a photo-lesion, and can lead to a kind of molecular injury called a dimer. Dimers prevent DNA from replicating properly, and cause genetic mutations that lead to diseases such as cancer.

The dimer in question is called a cyclobutane pyrimidine dimer, and it is shaped like a ring that juts out from the side of the DNA.

For those organisms lucky enough to have photolyase in their cells, the enzyme absorbs energy from visible light – specifically, blue light – to shoot an electron into the cyclobutane ring to break it up. The result is a perfectly repaired strand of DNA.

That's why photolyase-carrying insects, fish, birds, amphibians, marsupials, and even bacteria, viruses and yeast are all protected from cancer-causing UV rays from the sun. Meanwhile, humans and all other mammals lack the enzyme, and so are particularly vulnerable to UV.

A synthetic form of photolyase could make up for our enzymatic shortfall. But Zhong's group will leave that discovery to other researchers; they have now set their sights on photoreceptors – the proteins that absorb light and initiate signaling for many biological functions.

This research was funded by the National Institutes of Health, the Packard Foundation, the American Heart Association, and the Ohio State University Pelotonia fellowship.

Coauthors on the paper include Zheyun Liu, Chuang Tan, Xunmin Guo, Ya-Ting Kao, Jiang Li, and Lijuan Wang, all of Ohio State; and Aziz Sancar of the University of North Carolina School of Medicine, Chapel Hill.

Contact: Dongping Zhong, (614) 292-3044; Zhong.28@osu.edu
Written by Pam Frost Gorder, (614) 292-9475; Gorder.1@osu.edu

Dongping Zhong | EurekAlert!
Further information:
http://www.osu.edu

More articles from Life Sciences:

nachricht Immune Defense Without Collateral Damage
23.01.2017 | Universität Basel

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>